Average cost of multi drug-resistant tuberculosis treatment in Argentina
Argentina: Average cost of multi drug-resistant tuberculosis treatment was 1,547 constant 2022 US$ in 2024. ◆ Volatile
Average cost of multi drug-resistant tuberculosis treatment in Argentina, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Argentina recorded 1,547 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024.
The figure is up 110.5% on the previous year and down 74.2% over ten years.
That places Argentina 31st out of 92 countries with data for 2024, putting it in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Argentina, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 6,000 constant 2022 US$ | — |
| 2018 | 1,182 constant 2022 US$ | -80.3% |
| 2019 | 1,922 constant 2022 US$ | +62.6% |
| 2020 | 1,698 constant 2022 US$ | -11.7% |
| 2021 | 1,142 constant 2022 US$ | -32.7% |
| 2022 | 1,550 constant 2022 US$ | +35.7% |
| 2023 | 735 constant 2022 US$ | -52.6% |
| 2024 | 1,547 constant 2022 US$ | +110.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,035 constant 2022 US$ | 1,182 constant 2022 US$ | 6,000 constant 2022 US$ | 3 |
| 2020s | 1,334 constant 2022 US$ | 735 constant 2022 US$ | 1,698 constant 2022 US$ | 5 |
Countries ranked near Argentina
- 28 Dominican Republic 1,650 constant 2022 US$ compare
- 29 Kyrgyzstan 1,607 constant 2022 US$ compare
- 30 Georgia 1,600 constant 2022 US$ compare
- 32 Colombia 1,528 constant 2022 US$ compare
- 33 Nepal 1,526 constant 2022 US$ compare
- 34 Equatorial Guinea 1,500 constant 2022 US$ compare
- 34 Iraq 1,500 constant 2022 US$ compare
- 34 Mongolia 1,500 constant 2022 US$ compare
More health data for Argentina
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6333 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,462 deaths per 1,000 people (2090)
- Number of infants who die before age 1 684 deaths (2100)
- Population ages 75-79, female, annual growth rate 2.26 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0144 units per person (2025)
- Population ages 75-79, male, annual growth rate 3.05 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0104 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Argentina?
- Average cost of multi drug-resistant tuberculosis treatment in Argentina was 1,547 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Argentina?
- The highest recorded value was 6,000 constant 2022 US$ in 2017.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Argentina?
- The lowest recorded value was 735 constant 2022 US$ in 2023.
- How does Argentina rank for average cost of multi drug-resistant tuberculosis treatment?
- Argentina ranks 31st out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Argentina?
- Over the last ten years it is down 74.2%. The long-run trend across the full record is volatile.
- Where does this Argentina data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.